Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGEN CORP Director's Dealing 2020

Feb 7, 2020

32081_dirs_2020-02-07_275add27-8fc6-476e-a3ea-f801f3be3685.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGEN CORP (NEOG)
CIK: 0000711377
Period of Report: 2020-02-05

Reporting Person: Lilly Jason Warren (Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-05 Common Stock M 3892 $35.34 Acquired 14293 Direct
2020-02-05 Common Stock S 3892 $70.02 Disposed 10401 Direct
2020-02-06 Common Stock M 273 $35.34 Acquired 10674 Direct
2020-02-06 Common Stock M 1199 $40.4625 Acquired 11873 Direct
2020-02-06 Common Stock S 1472 $70.01 Disposed 10401 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-05 Common Stock (Right to Buy) $35.34 M 3892 Disposed 2020-11-08 Common Stock (3892) Direct
2020-02-06 Common Stock (Right to Buy) $35.34 M 273 Disposed 2015-11-08 Common Stock (273) Direct
2020-02-06 Common Stock $40.4625 M 1199 Disposed 2021-10-29 Common Stock (1199) Direct

Footnotes

F1: Options were granted on 108/2015, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant

F2: Options were granted on 9/29/2016, have five year lives,and vest in equal annual 20% installments on each of the first five anniversary dates of the grant